Johnson & Johnson Wound Management offers a complete line of products to meet the advanced and general wound care needs of health care professionals.
The wound care portfolio builds on Johnson & Johnson’s long-standing commitment to skin and wound care that continues today with innovative products. The portfolio consists of five key areas: Advanced Wound Care, IV Site Care, Infection Control, Patient Skin Care, and General Wound Care.
The surgical wound care business primarily focuses on hemostasis and tissue regeneration products. Hemostasis products are used by surgeons to control mild to moderate bleeding when conventional means, such as suture or ligature, are ineffective. The product line offers the greatest choice of hemostasis products available, and utilizes our exclusive oxidized regenerated cellulose technology. The tissue regeneration products deliver superior functional and cosmetic outcomes in treating post excisional wounds, full-thickness skin defects and tissue deficits.
